A new review has found that social media influencers who promote prescription medications frequently spread misleading information, and that current regulations have failed to keep up with the practice.
The research, reported by Healthline, was led by Raffael Heiss, a professor at the Management Center Innsbruck in Austria. His team found that influencer-driven drug promotion is often tied to outdated regulatory oversight and that audiences struggle to identify when they are being marketed to.
"Influencers often share advice about prescription drugs despite having financial incentives or little medical expertise," Heiss said. "Existing rules and disclosure requirements have not kept pace with social media."
Part of what makes the content so effective is its format. Personal stories, often from patients who are genuinely living with a condition, give promotional posts an emotional authenticity that traditional advertising lacks. Followers may connect with the storyteller before they ever consider whether the content is a paid promotion.
"Personal stories can also make promotional content feel trustworthy and authentic, even when it is incomplete or misleading," Heiss said. "As a result, followers may trust influencers because they emotionally connect with their stories and may not recognize that the content is advertising."
Pharmaceutical companies have increasingly turned to so-called "patient influencers" — people managing real illnesses who attract large online followings by documenting their health journeys. That combination of lived experience and wide reach makes them persuasive partners for drug brands, but the review warns that it also makes the promotional intent harder for audiences to detect.
The problem is compounded when healthcare professionals themselves act as influencers. The review notes that this blurs the line between clinical guidance and commercial content in ways that can be particularly difficult for the public to parse.
Kanwar Kelley, a physician triple board-certified in otolaryngology, obesity medicine, and lifestyle medicine, and co-founder of Side Health in Orinda, California, said the phenomenon exploits gaps in how people process health information online. "In today's social media, that content is nearly indistinguishable from professional advice and can skirt the skepticism that people apply to traditional prescription marketing," Kelley said. He was not involved in the study.
Beyond individual confusion, the review points to a broader public health concern: influencer-driven demand for specific medications can encourage inappropriate use, harmful drug interactions, or pressure on physicians to prescribe drugs that may not be suitable for a given patient.
The researchers are calling for updated regulatory guidance and stronger, standardized disclosure requirements that reflect how social media actually works. Under current rules, disclosures are often buried, inconsistently applied, or formatted in ways that users scroll past without registering.
The review stops short of dismissing all patient influencer content as harmful. In some cases, patients sharing their experiences can provide genuine community support and help others navigate complex diagnoses. But the researchers argue that the line between support and promotion needs to be far clearer, and that the responsibility for drawing it should not fall on the audience alone.
